Monday, October 10, 2011
Steven Schiff, director of the Penn State Center for Neural Engineering, will present "The Brain: The Final Frontier. Neural Engineering at Penn State" as this weekend's Huddle with the Faculty event. Sponsored by the Penn State Alumni Association, Huddle with the Faculty is presented every home football Saturday morning at the Nittany Lion Inn. The free event starts at 8:30 a.m. with a free continental breakfast and Schiff's presentation at 9 a.m. (more)
Monday, August 08, 2011
Testimony by Steven Schiff, director of the Penn State Center for Neural Engineering and Brush Chair Professor of Engineering, before the U.S. House of Representatives Committee on Foreign Affairs, Subcommittee on Africa, Global Health and Human Rights, is now available for online viewing. (more)
Tuesday, March 08, 2011
Steven J. Schiff, professor of neurosurgery, Penn State Milton S. Hershey Medical Center and Penn State College of Medicine, will give the first talk of the 2011 Research Unplugged season at noon on Wednesday, March 16, at the Penn State Downtown Theatre in State College. His talk is titled "Untangling an African Medical Mystery: Engineering Solutions to Infant Brain Infections." (more)
Wednesday, July 07, 2010
On June 5, Penn State Milton S. Hershey Medical Center's neurosurgeons took their skills to a softball field in New York to participate in the seventh annual Neurosurgery Charity Softball Tournament. The event raises money for pediatric brain tumor research and over the years has raised nearly $200,000. (more)
Wednesday, March 17, 2010
Dr. Robert E. Harbaugh, director, Penn State Institute of the Neurosciences and distinguished professor and chair, Department of Neurosurgery, Penn State Milton S. Hershey Medical Center, has been appointed to a six-year term as a director of the American Board of Neurological Surgery (ABNS). The goal of the ABNS is to encourage the study, improve the practice, elevate the standards, and advance the science of neurological surgery and thereby to serve the cause of public health. (more)
Wednesday, January 28, 2009
High levels of certain proteins in the spinal fluid could signal the onset of Lou Gehrig's disease, according to researchers. The discovery of these biomarkers may lead to diagnostic kits for early diagnosis, accurately measuring the progression of the disease and monitoring the effects of treatment. "The disease has to progress far enough so that the patient begins to experience significant muscle weakness, so that a physician can identify the problem," said James Connor, distinguished professor and vice-chair of neurosurgery, Penn State Hershey Medical Center. "If we had a biomarker we could start treatments earlier and perhaps save more nerve cells and slow the disease." (more)
